Physician profile
Aida M Sanchez
NPI 1285734756
$2,154.66
in general payments reported to CMS, 2019-2025
15 companies · $765 in 2025
The $765 reported for 2025 was more than what 89% of General Practice providers received nationally (typical 2025 total: $105).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $233 · 2021: $36.71 · 2022: $250 · 2023: $216 · 2024: $653 · 2025: $765.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,634.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,634.16 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $424.36 | 2019-2024 | Xarelto |
| Boston Scientific Corporation | $284.68 | 2019-2025 | Lux-Dx Insertable Cardiac Monitor, Patientcare Link |
| Boehringer Ingelheim Pharmaceuticals, INC. | $269.82 | 2023-2025 | Jardiance, Synjardy |
| Medtronic, INC. | $206.89 | 2023-2025 | Endurant Iis, Corevalve Evolut R |
| Astrazeneca Pharmaceuticals LP | $187.51 | 2019-2025 | Lokelma, Farxiga |
| Abbott Laboratories | $166.41 | 2024-2025 | Aveir, Assurity |
| Bayer Healthcare Pharmaceuticals INC. | $125.00 | 2024 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $114.36 | 2023-2025 | Lifevest |
| Rhythm Pharmaceuticals, INC. | $84.47 | 2024 | Imcivree |
| Dexcom, INC. | $79.44 | 2025 | Dexcom G6 Transmitter |
| Amgen INC. | $74.19 | 2025 | Repatha |
| Merck Sharp & Dohme LLC | $48.27 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $47.97 | 2019-2021 | |
| Pbg Puerto Rico LLC | $21.73 | 2021 | |
| Baxter Healthcare | $19.56 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Aida Sanchez listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.